The role of CXC chemokines and their receptors in cancer

被引:542
作者
Vandercappellen, Jo [1 ]
Van Damme, Jo [1 ]
Struyf, Sofie [1 ]
机构
[1] Univ Louvain, Rega Inst Med Res, Lab Mol Immunol, B-3000 Louvain, Belgium
关键词
angiogenesis; cancer; chemokines; GPCR; metastasis; tumorigenesis;
D O I
10.1016/j.canlet.2008.04.050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemokines. or chemotactic cytokines. and their receptors have been discovered as essential and selective mediators in leukocyte migration to inflammatory sites and to secondary lymphoid organs. Besides their functions in the immune system, they also play a critical role in tumor initiation. promotion and progression. There are four subgroups of chemokines: CXC, CC, CX3C. and C chemokine ligands. The CXC or alpha subgroup is further subdivided in the ELR+ and ELR chemokines. Members that contain the ELR motif hind to CXC chemokine receptor 2 (CXCR2) and are angiogenic. In contrast, most of the CXC chemokines without ELR motif bind to CXCR3 and are angiostatic. Ail exception is the angiogenic ELR-CXC chemokine stromal cell-derived factor-1 (CXCL12/SDF-1). which binds to CXCR4 and CXCR7 and is implicated in tumour metastasis. This review is focusing oil the role of CXC chemokines and their receptors in tumorigenesis, including angiogenesis. attraction of leukocytes to tumour sites and induction of tumour Cell migration and homing in metastatic sites. Finally, their therapeutic Use In Cancer treatment is discussed. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:226 / 244
页数:19
相关论文
共 193 条
  • [61] Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells
    Hromas, R
    Broxmeyer, HE
    Kim, C
    Nakshatri, H
    Christopherson, K
    Azam, M
    Hou, YH
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (03) : 703 - 706
  • [62] Interaction of Duffy antigen receptor for chemokines and KAl1: a critical step in metastasis suppression
    Iiizumi, Megumi
    Bandyopadhyay, Sucharita
    Watabe, Kounosuke
    [J]. CANCER RESEARCH, 2007, 67 (04) : 1411 - 1414
  • [63] Inoue K, 2001, ONCOL REP, V8, P955
  • [64] Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor
    Jenh, CH
    Cox, MA
    Hipkin, W
    Lu, TH
    Pugliese-Sivo, C
    Gonsiorek, W
    Chou, CC
    Narula, SK
    Zavodny, PJ
    [J]. CYTOKINE, 2001, 15 (03) : 113 - 121
  • [65] Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action
    Jouan, V
    Canron, X
    Alemany, M
    Caen, JP
    Quentin, G
    Plouet, J
    Bikfalvi, A
    [J]. BLOOD, 1999, 94 (03) : 984 - 993
  • [66] Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro
    Juarez, J
    Bradstock, KF
    Gottlieb, DJ
    Bendall, LJ
    [J]. LEUKEMIA, 2003, 17 (07) : 1294 - 1300
  • [67] Kamohara H, 2007, INT J ONCOL, V31, P627
  • [68] Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth
    Kaneko, Tomoatsu
    Zhang, Zhaocheng
    Mantellini, Maria G.
    Karl, Elisabeta
    Zeitlin, Benjamin
    Verhaegen, Monique
    Soengas, Maria S.
    Lingen, Mark
    Strieter, Robert M.
    Nunez, Gabriel
    Nor, Jacques E.
    [J]. CANCER RESEARCH, 2007, 67 (20) : 9685 - 9693
  • [69] A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions
    Kashiwazaki, M
    Tanaka, T
    Kanda, H
    Ebisuno, Y
    Izawa, D
    Fukuma, N
    Akimitsu, N
    Sekimizu, K
    Monden, M
    Miyasaka, M
    [J]. INTERNATIONAL IMMUNOLOGY, 2003, 15 (10) : 1219 - 1227
  • [70] Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
    Kawada, K.
    Hosogi, H.
    Sonoshita, M.
    Sakashita, H.
    Manabe, T.
    Shimahara, Y.
    Sakai, Y.
    Takabayashi, A.
    Oshima, M.
    Taketo, M. M.
    [J]. ONCOGENE, 2007, 26 (32) : 4679 - 4688